EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and molecular evidences of HTLV-1 infection in inpatients diagnosed with diseases previously described as associated to this infection: A case series in Gabon, Central Africa

Eldridge Fedricksen Oloumbou, Léonie Ledaga Lentombo, Judicaël Obame-Nkoghe, Josaphat Iba-Ba, Jeordy Dimitri Engone Ondo, Christ Ognari Ayoumi, Moussa Yaro, Abdoulaye Diané, Philomène Kouna Ndouongo, Jean-Bruno Boguikouma, Ivan Mfouo-Tynga, Augustin Mouinga-Ondémé iD

PLOS Neglected Tropical Diseases · 2025

DOI: 10.1371/journal.pntd.0013075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2025. Verfasst von Eldridge Fedricksen Oloumbou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Unité des Infections Rétrovirales et Pathologies associées, Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville, Ga…. Hauptthemen laut MEDLINE: HTLV-I Infections, Human T-lymphotropic virus 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Human T-cell Leukemia Virus Type 1 (HTLV-1) infection is endemic in Gabon, and despite the high prevalence, very few cases of HTLV-1 associated diseases are sporadically described. A cross-sectional study was conducted in the main teaching hospital of Gabon. Using serological and molecular techniques, plasma samples were tested and nucleic materials of all positive samples extracted from the buffy coat, then a polymerase chain reaction (PCR) was performed to detect fragments of 220 and 522-base-pairs of HTLV-1 Tax/Rex and Env genes, respectively. From March to September 2022, a total of 352 participants (51 median age, IQR 36–62) were recruited, consisting of 290 (82.4%) patients and 65 (17.6%) patients’ family members. Of them, 36 (10.2%) samples were ELISA seropositive, and according to WB criteria, 22 were HTLV-1 positive (6.3%), 7 indeterminate (2%), 5 seronegative (1.4%) and 2 had HTLV seroreactivity (0.6%). The HTLV-1 infection was confirmed in 26 individuals (22 patients and 4 among their family members) with an overall prevalence estimated at 7.39% (26/352), and 3.7% (10/272) prevalence for diseases associated to HTLV-1, obtained from all clinical diagnoses. The link assessment between HTLV-1 infection and diseases’ occurrence revealed 10.5% of cases of Adult T-cell Leukemia/Lymphoma (2/19), 55.6% of tropical spastic paraparesis/HTLV-1-associated myelopathy (5/9) and 60% of inflammatory myopathies (3/5). Most of the detected genotypes of HTLV-1 strains belonged to the central African HTLV-1b, four defined as HTLV-1a including a-Na, a-Wa and a-TC subclades, and one belonging to the HTLV-1d. Then, assessment of HTLV-1 intrafamilial transmission and risk factors reported one case of mother-to-child HTLV-1 transmission, and significant impacts of association between HTLV-1 infection with the gender and birthplaces were observed. Here, we discussed both the prevalence of HTLV-1 infection among patients and diseases previously described as associated to this retrovirus in Gabon. Our findings highlight the necessity to develop strategies to prevent and properly manage this infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HTLV-I InfectionsHuman T-lymphotropic virus 1HumansGabonMiddle AgedAdultMaleFemaleCross-Sectional StudiesInpatientsPrevalenceAged

Autor:innen und Institutionen

  • Unité des Infections Rétrovirales et Pathologies associées, Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville, Gabon.
  • Service de Médecine Interne, Centre Hospitalier Universitaire de Libreville (CHUL), Libreville, Gabon.
  • Département de Médecine Interne, Université des Sciences de la Santé (USS), Libreville, Gabon.
  • Département de biologie, Université des Sciences et Techniques de Masuku (USTM), Franceville, Gabon.
  • Unité Écologie des Systèmes Vectoriels (ESV), Centre Interdisciplinaire de Recherches Médicales de Franceville (CIRMF), Franceville, Gabon.
  • Service de Neurologie, Centre Hospitalier Universitaire de Libreville (CHUL), Libreville, Gabon.

ORCID-Profile: Augustin Mouinga-Ondémé

Zitieren

APA

Oloumbou, E. F., Ledaga Lentombo, L., Obame-Nkoghe, J., Iba-Ba, J., Engone Ondo, J. D., Ognari Ayoumi, C., Yaro, M., Diané, A., Kouna Ndouongo, P., Boguikouma, J. B., Mfouo-Tynga, I., & Mouinga-Ondémé, A. (2025). Clinical and molecular evidences of HTLV-1 infection in inpatients diagnosed with diseases previously described as associated to this infection: A case series in Gabon, Central Africa. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0013075

Vancouver

Oloumbou EF, Ledaga Lentombo L, Obame-Nkoghe J, Iba-Ba J, Engone Ondo JD, Ognari Ayoumi C, et al. Clinical and molecular evidences of HTLV-1 infection in inpatients diagnosed with diseases previously described as associated to this infection: A case series in Gabon, Central Africa. PLOS Neglected Tropical Diseases. 2025. doi:10.1371/journal.pntd.0013075

BibTeX
@article{Oloumbou2025,
  author = {Oloumbou, Eldridge Fedricksen and Ledaga Lentombo, Léonie and Obame-Nkoghe, Judicaël and Iba-Ba, Josaphat and Engone Ondo, Jeordy Dimitri and Ognari Ayoumi, Christ and Yaro, Moussa and Diané, Abdoulaye and Kouna Ndouongo, Philomène and Boguikouma, Jean-Bruno and Mfouo-Tynga, Ivan and Mouinga-Ondémé, Augustin},
  title = {Clinical and molecular evidences of HTLV-1 infection in inpatients diagnosed with diseases previously described as associated to this infection: A case series in Gabon, Central Africa},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  doi = {10.1371/journal.pntd.0013075}
}
Kostenlos starten →